FDA to Review Certain Diabetes Drugs Over New Pancreas Concern (BMY) (LLY) (MRK)
Go back to FDA to Review Certain Diabetes Drugs Over New Pancreas Concern (BMY) (LLY) (MRK)| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 67.01 +1.54 (2.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.47 | 52 Week High | $77.12 | |||
| Open | $65.79 | 52 Week Low | $49.03 | |||
| Day High | $67.55 | P/E | 43.51 | |||
| Day Low | $65.13 | EPS | $1.54 | |||
| Volume | 7,932,248 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1255.40 +11.00 (0.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1244.40 | 52 Week High | $88.16 | |||
| Open | $1232.00 | 52 Week Low | $67.88 | |||
| Day High | $1271.22 | P/E | 290.60 | |||
| Day Low | $1230.00 | EPS | $4.32 | |||
| Volume | 2,505,585 | |||||
| McKesson Corp. (NYSE: MCK) | Delayed: 858.90 +20.15 (2.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $838.75 | 52 Week High | $202.20 | |||
| Open | $839.84 | 52 Week Low | $114.53 | |||
| Day High | $867.92 | P/E | 160.24 | |||
| Day Low | $837.88 | EPS | $5.36 | |||
| Volume | 1,580,735 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 46.74 +0.60 (1.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $46.14 | 52 Week High | $59.00 | |||
| Open | $46.35 | 52 Week Low | $32.80 | |||
| Day High | $47.17 | P/E | N/A | |||
| Day Low | $46.34 | EPS | $0.00 | |||
| Volume | 10,898,849 | |||||
